Improvement of therapy-induced myelodysplastic syndrome by infusion of autologous CD34-positive hematopoietic progenitor cells without chemotherapy

Leuk Lymphoma. 2020 Dec;61(13):3259-3262. doi: 10.1080/10428194.2020.1804562. Epub 2020 Aug 28.

Anne-Sophie Alary^{1

2}, Marguerite Vignon^{1

3}, Raphael Carapito⁴, Najeeb Halabi⁵, Lise Willems^{1

3}, Alexa Green^{1

2}, Nicolas Chapuis^{1

2}, Farhad Heshmati^{1

6}, Wendy Cuccuini⁷, Sophie Kaltenbach⁸, Isabelle Radford-Weiss⁸, Olivier Kosmider^{1

3}, Didier Bouscary^{1

3}, Seiamak Bahram⁴, Arash Rafii⁵, Jerome Tamburini^{1

3}

¹ CNRS UMR8104, Institut Cochin, Université de Paris, INSERM U1016, Paris, France.
² Hematology Laboratory, Cochin Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
³ Hematology Department, Cochin Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
⁴ Laboratoire d'ImmunoRhumatologie Moléculaire, plateforme GENOMAX, INSERM UMR_S 1109, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), LabEx TRANSPLANTEX, Université de Strasbourg, Strasbourg, France.
⁵ Stem Cell and Microenvironment Laboratory, Weill Cornell Medical College in Qatar, Education City, Qatar Foundation, Doha, Qatar.
⁶ Apheresis Unit, Cochin Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
⁷ Hematology Laboratory, Saint Louis Hospital, AP-HP, Paris, France.
⁸ Cytogenetic Unit, Necker Hospital, AP-HP, Paris, France.

No abstract available

Publication types